DIA 2013 49th Annual Meeting
Click here to go to the previous page
Development of a New Patient-reported Outcome (PRO) Measure for Depression: Progress and Results from the PRO Consortium
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 209
Date: Tuesday, June 25, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 251
CHAIR :
 Stephen Joel Coons, PhD,MEd,MSc (SCHNON), Executive Director, PRO Consortium, Critical Path Institute, United States
SPEAKER (S):
 Elektra Johanna Papadopoulos, DrMed,MPH (SPKAGY), Medical Officer, Office of New Drugs, CDER, FDA, United States
 Steven I. Blum, MA,MBA (SPKNON), Director, Health Economics, Forest Research Institute, United States
 Mona L. Martin, MPA,RN (SPKNON), Executive Director, Research Scientist, Health Research Associates Inc., United States
Description
Gain an understanding of the research conducted by the PRO Consortium's Depression Working Group to develop a new patient-reported outcome (PRO) measure for depression which is intended for use as an endpoint to support medical product labeling.